The JAK inhibitor #ruxolitinib was found to alleviate severe intractable diarrhea following treatment with cilta-cel in a small series of patients with #MultipleMyeloma #MMsm, offering clinical improvement to patients experiencing symptoms: https://ow.ly/u7Jc50YFG8g
#HemeSky #MedSky #myeloma
Got a shock when he arrived as she was sitting in a chair waiting for him bright as a button . 😂😂😂😂😂😂just fluctuating #BP apart from #DRDoom the consensus is medication tweak.
#mymumsgotcancer #myeloma #multiplemyeloma.
Received a call from the out of hours GP. I have looked at your mothers records & conditions .Has the district nurse left morphine .I think she is in the end of life final phase. He assessed the records not the person.
#mymumsgotcancer #myeloma #multiplemyeloma
This was Drake Ward. Single room to minimise chance of infections.
#mymumsgotcancer #myeloma #multiplemyeloma. #harrow
Unfortunately had to restart this today.Hopefully not for long . #oxygenator
#mymumsgotcancer #myeloma #multiplemyeloma.
#Cleveland #myeloma community, join us for 2 days of support, community, and learning! We want to see you there on May 1-2, 2026. The event is free, but seats are limited. Register now to join us: https://mmsm.link/3LDPSxS
Two yrs ago I was anemic, and soon to be diagnosed with Multiple Myeloma. Now I'm in maintenance with Minimal Residual Disease. I have good insurance and a great oncology team. I take my meds, and monthly blood test and oncology visit. I have to remind myself that I'm a cancer patient. #myeloma
New to #myeloma? Join our FREE Virtual Myeloma Community Workshop: “I Have WHAT?” Learn about diagnosis, treatment options, and side effects. April 20 at 6PM ET. Register now at https://mmsm.link/4te5zMh
Then, check out the commentary, "No BCMA? No Problem: A CD70-Targeting CAR-NK Cell Shows Promise in High-risk #Myeloma." buff.ly/rHuA6X2
Blood cancer care is evolving fast. New advances in treating multiple myeloma are changing what was once considered a very difficult disease into something far more manageable. Real hope, backed by science.
#BloodCancer #Myeloma #TCSC
news.llu.edu/health-welln...
Keeping connected can be important for emotional wellbeing and this is just as important as your physical health. Try to stay connected with family, friends, pets and support groups.
What wellness practices help you? Share your tips in the comments.
#WellnessWednesday #Myeloma
✅️ Navigate emerging immunotherapies including CAR T-cell therapies and bispecific antibodies
✅️ Identify the role of novel agents such as antibody-drug conjugates in relapsed and refractory settings
#Hematology #HematologyOncology #Myeloma #MyelomaAwareness #BloodCancer #PlasmaCellDisorder
Researchers at Sylvester Myeloma Institute report rapid growth in myeloma clinical trials, precision medicine and new drug development, with 29 open studies and more on the way. #Myeloma #CancerResearch #TCSC
news.med.miami.edu/sylvester-my...
Title page and abstract: Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple Myeloma Ehsan Malek, MD 1 ; Brian Betts, MD 1 ; Megan Herr, PhD 1 ; Marco Davila, MD 1 ; Shernan Holtan, MD 1 ; James J. Driscoll, MD, PhD 2,3 ; and Han Yu, PhD 1
FIG 3. Cost breakdown by strategy. Stacked bar chart of per-patient costs for the no-boost and boost strategies. In the no-boost arm, all costs are attributable to hospitalization for infection. In the boost arm, upfront reserve collection accounts for the majority of costs, while infection-related costs are markedly lower. Total costs for each strategy represent the sum of upfront collection/storage fees and longitudinal infection-related hospitalization costs. USD, US dollars. Figure demonstrates cost per patient >$20,000 in boost group, under $5000 in no boost group. Majority of costs attributable to cost of stem cell collection up-front.
Should we be reserving stem cells for every patient with #myeloma treated with BCMA CAR T?
Reduces severe infections by over half, but >4x cost. Need risk-stratification (or IVIG) to make sustainable.
Cost effectiveness modeling in #JCOCCI :
ascopubs.org/doi/10.1200/...
@ziadbakouny.bsky.social
Doing a bit of coaching for @yazmyelomaride 😂
Please donate
ride.myeloma.org.uk/yas-ashburnham
#myeloma #canyonaeroadcfr #djimimo
Communication about Multiple Myeloma is extremely difficult. Terms that are either extremely complex or vaguely dumbed down. I decided to start from the beginning and read "Hematology for Beginners" by Richard J. Brooks. It is aimed at a high school audience. Very helpful. #Myeloma
Compared with #pomalidomide and #dexamethasone, #venetoclax and dexamethasone did not produce statistically different PFS in those with R/R t(11;14) multiple #myeloma #MMsm, an indication that the combo may not be a good option in this patient population: https://ow.ly/Z0Pf50YsTST
#HemeSky #MedSky
Multiple Myeloma Treatment 2026: CAR-T vs Bispecific Antibodies (Evidence-Based Guide) Introduction: A Turning Point in Multiple Myeloma (2026) The treatment landscape for multiple myeloma has unde...
#cancer #CAR-T #immunotherapy #multiple #myeloma
Origin | Interest | Match
Multiple Myeloma Treatment 2026: CAR-T vs Bispecific Antibodies (Evidence-Based Guide) Introduction: A Turning Point in Multiple Myeloma (2026) The treatment landscape for multiple myeloma has unde...
#cancer #CAR-T #immunotherapy #multiple #myeloma
Origin | Interest | Match
Test Your Knowledge: The @ascopost.bsky.social has partnered with @ontariohealth.bsky.social to issue a series of guidelines regarding the management of #multipleMyeloma.
https://bit.ly/4sEqGqD
#myeloma #ClinicalQuiz
New paper alert 🚨‼️
Our myeloma team and colleagues from across the glob have published their primary analysis of their Phase III ATLAS trial in @thelancet.com! Read it at www.thelancet.com/journals/lan...
#AtTheForefront #Myeloma #ClinicalTrials #CancerResearch #OncSky #MedSky
According to results from a recent phase II study, most patients with drug-resistant, true #extramedullary #myeloma responded to dual treatment with #talquetamab plus #teclistamab, with researchers observing a 61% PFS and 74% OS at 12 months: https://ow.ly/q6gI50YpblV #MMsm
#HemeSky #MedSky
The March issue is out now! Issue highlights include a feature on #AI in medical education, a look at POEMS syndrome, dual-targeting therapy in #extramedullary #myeloma, and more. Check out the full issue lineup here: https://ow.ly/57Ym50YoBJm
#HemeSky #MedSky
🩸🔬 Today’s questions!
The first question explores mechanisms #myeloma cells use to “escape” immune surveillance.
The second question highlights immune characteristics in patients who reach “immune normalization.”
Swipe to review answers and explanations!
#MultipleMyeloma #MedEd #HEMEHUB #MedEd
#Detroit community! If you're affected by #myeloma, join us at our FREE Myeloma Community Workshop on June 27! Learn about myeloma treatment options, get your questions answered by the experts, and so much more. Sign up now before spots are gone: https://mmsm.link/4qz1zVQ
#mmsm
#TreatmentTuesdays
Personalised treatment based on fitness? Can we better tailor myeloma treatment according to a patient's level of fitness and frailty?
Dr. Charlotte Pawlyn discusses the UK MRA FiTNESS trial.
https://f.mtr.cool/beuzpfczod
#myeloma
#organoids #organ-on-chip #myeloma #NAMs #myeloma @imm.ox.ac.uk
You don't have to face #myeloma or #ALamyloidosis alone.
MPE's 52 member organisations across 33 countries offer local expertise, peer support and advocacy. Find information, community and help navigating your healthcare system: https://f.mtr.cool/qnokbybxhw
#WellnessWednesday
Newly diagnosed? Understanding #myeloma starts with the basics.
Get clear, trusted information about what multiple myeloma is and how it’s treated.
https://www.myeloma.org/what-is-multiple-myeloma
